Medline Inc. (MDLN) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, Medline reported revenue of $28.43B. Net income was $1.16B (a 4.1% net margin), or -$0.01 per diluted share. Gross margin was 26.4% and operating margin was 7.8%. Operating activities generated $1.74B of cash, leaving $1.30B of free cash flow. At fiscal year end, Medline held $38.48B in total assets against $19.20B in total liabilities, including $1.94B of cash and equivalents.
Open the full interactive Medline financials → Quarterly statements, key ratios, valuation history and price charts.
Medline Key Stats
| Share Price | $35.70 |
|---|---|
| Market Cap | $30.73B |
| 52-Week Range | $31.64 – $49.99 |
| Shares Outstanding | 856.7 million (basic, 2026 Q2) |
Medline Income Statement
| FY 2025 | |
|---|---|
| Revenue | $28.43B |
| Cost of Goods Sold | $20.91B |
| Gross Profit | $7.52B |
| Operating Income | $2.21B |
| Pre-Tax Income | $1.25B |
| Income Tax | $91.0M |
| Net Income | $1.16B |
| Diluted EPS | -$0.01 |
Medline Quarterly Results
| 2026 Q1 | 2026 Q2 | |
|---|---|---|
| Revenue | $7.35B | $7.68B |
| Net Income | $129.0M | $60.0M |
| Diluted EPS | $0.16 | $0.07 |
Medline Balance Sheet
| FY 2025 | |
|---|---|
| Cash & Equivalents | $1.94B |
| Current Assets | $10.68B |
| Total Assets | $38.48B |
| Current Liabilities | $2.49B |
| Total Long-Term Debt | $12.56B |
| Total Liabilities | $19.20B |
| Shareholders' Equity | $10.74B |
Medline Cash Flow Statement
| FY 2025 | |
|---|---|
| Cash From Operations | $1.74B |
| Cash From Investing | -$474.0M |
| Cash From Financing | $399.0M |
| Free Cash Flow | $1.30B |
Figures from Medline's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Medline financials page for every line item.
Medline Company Profile
| Ticker | MDLN |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Northfield, Illinois |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer |
| SEC CIK | 0002046386 |
Frequently Asked Questions
What was Medline's revenue in fiscal 2025?
Medline (MDLN) reported revenue of $28.43B for fiscal 2025.
What was Medline's net income in fiscal 2025?
Medline reported net income of $1.16B for fiscal 2025.
What was Medline's earnings per share (EPS) in fiscal 2025?
Medline's diluted EPS was -$0.01 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Medline generate in fiscal 2025?
Medline generated $1.30B of free cash flow in fiscal 2025.
What was Medline's revenue last quarter?
In its most recent reported quarter (2026 Q2), Medline reported revenue of $7.68B.
How much debt does Medline have?
Medline reported $12.56B of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Medline are outstanding?
Medline reported a weighted average of 856.7 million basic shares outstanding in 2026 Q2.
What is Medline's market cap?
Based on its latest closing price, Medline (MDLN) has a market capitalization of about $30.73B.
When does Medline's fiscal year end?
Medline's fiscal year end, as registered with the SEC, is December 31.
Where is Medline headquartered?
Medline lists its business address in Northfield, Illinois in its SEC filings.